Enhancing the expression and activation of TLR4/MyD88/NF-kB pathway in the placentae may increase the generation and release of inflammatory cytokines and bio-mediator, which will affect the insulin signaling and result in a significant deterioration of insulin sensitivity in GDM placenta. Here, NFKB1 is linked to gestational diabetes.